James A Underberg

发表

LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design.

Z. Fayad, D. Blom, James A. Underberg, 2016, Journal of clinical lipidology.

ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Compete

Paul D. Thompson, Lawrence J. Fine, B. Franklin, 2009, Journal of the American College of Cardiology.

Lawrence J. Fine, B. Franklin, G. Mensah, 2009, Circulation.

Use of health information technology (HIT) to improve statin adherence and low-density lipoprotein cholesterol goal attainment in high-risk patients: proceedings from a workshop.

Alan S. Brown, Matthew K. Ito, D. Karalis, 2013, Journal of clinical lipidology.

Niacin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients

James A. Underberg, H. Tran, A. Schwartzbard, 2014 .

Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention

Binita Shah, E. Fisher, Lisa Tully, 2015, Diabetes/metabolism research and reviews.

LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals

James A. Underberg, P. Toth, Fatima Rodriguez, 2022, Postgraduate medicine.

Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association.

Alan S. Brown, A. Gotto, J. Saseen, 2017, Journal of clinical lipidology.

Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association.

R. Hegele, A. Sturm, L. Braun, 2020, Journal of clinical lipidology.

Laparoscopic gastric banding resolves the metabolic syndrome and improves lipid profile over five years in obese patients with body mass index 30-40 kg/m(2.).

Amita Singh, James A. Underberg, S. Heffron, 2014, Atherosclerosis.

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.

J. Mckenney, S. Grundy, S. Daniels, 2015, Journal of clinical lipidology.

Resistant Hypertension and Sleep Apnea: Pathophysiologic Insights and Strategic Management

G. Jean-Louis, F. Zizi, Samy I McFarlane, 2011, Current diabetes reports.

The Recent National Lipid Association Recommendations: How Do They Compare to Other Established Dyslipidemia Guidelines?

J. Newman, James A. Underberg, L. Flink, 2015, Current Atherosclerosis Reports.

What is sufficient drug therapy for lipoprotein elevations?

Alan S. Brown, James A. Underberg, W. Brown, 2017, Journal of clinical lipidology.

Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial

E. Fisher, J. Berger, J. Newman, 2018, American heart journal.

Rhabdomyolysis in a Patient Taking Colchicine and Rosuvastatin

V. Milne, James A Underberg, J. Carral, 2014 .

New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?

Marc P. Bonaca, D. Atar, A. Keech, 2021, Atherosclerosis.

Lysosomal Acid Lipase Deficiency

J. Parham, James A Underberg, 2020, Contemporary Cardiology.

Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.

Emily C. O'Brien, J. Knowles, D. Rader, 2017, Atherosclerosis.

The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis

James A. Underberg, M. Garshick, James A Underberg, 2017, Current Atherosclerosis Reports.

Characterization of PCSK9 in the Blood and Skin of Psoriasis.

T. Powell-Wiley, E. Fisher, N. Mehta, 2020, The Journal of investigative dermatology.

Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.

Emily C. O'Brien, J. Knowles, D. Rader, 2019, Atherosclerosis.

Abstract 19888: Improved Longitudinal Low Density Lipoprotein Cholesterol Goal Achievement Among Familial Hypercholesterolemia Patients in the CASCADE FH Patient Registry

Emily C. O'Brien, J. Knowles, D. Rader, 2017 .

Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.

Emily C. O'Brien, J. Knowles, D. Rader, 2014, American heart journal.

Suboptimal risk factor control in patients undergoing elective coronary or peripheral percutaneous intervention.

R. Stein, E. Fisher, Lisa Tully, 2014, American heart journal.

Case study: women and cardiovascular risk

James A Underberg, 2006 .

PCSK9 inhibitor access barriers—issues and recommendations: Improving the access process for patients, clinicians and payers

P. Jellinger, James A. Underberg, P. Toth, 2017, Clinical cardiology.

New Treatment Approaches for Dyslipidemia and its Management

James A. Underberg, Matthew Vorsanger, James A Underberg, 2013, Current Cardiovascular Risk Reports.

Management of Hypogonadism in Cardiovascular Patients: What Are the Implications of Testosterone Therapy on Cardiovascular Morbidity?

James A. Underberg, E. Gianos, A. Schwartzbard, 2016, The Urologic clinics of North America.

Lowering LDL‐Cholesterol and CV Benefits: Is There a Limit to How Low LDL‐C Needs to be for Optimal Health Benefits?

James A. Underberg, A. Vani, James A Underberg, 2018, Clinical pharmacology and therapeutics.

Dapagliflozin in patients with type II diabetes mellitus, with and without elevated triglyceride and reduced high-density lipoprotein cholesterol levels.

P. Sartipy, H. Bays, James A. Underberg, 2017, Journal of clinical lipidology.

Cardiovascular Effects of the New Weight Loss Agents.

I. Goldberg, James A. Underberg, P. Subramanyam, 2016, Journal of the American College of Cardiology.

Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry

J. Knowles, D. Rader, C. Ballantyne, 2023, Journal of the American Heart Association.

Diagnosing Familial Hypercholesterolemia (FH) in the United States: Results from the CASCADE FH Patient Registry*†

Emily C. O'Brien, J. Knowles, D. Rader, 2015 .

INITIAL RESULTS FROM THE CASCADE-FH REGISTRY: CASCADE SCREENING FOR AWARENESS AND DETECTION OF FAMILIAL HYPERCHOLESTEROLEMIA

Emily C. O'Brien, J. Knowles, D. Rader, 2015 .

Lack of Pharmacokinetic Interactions Between Pitavastatin and Efavirenz or Darunavir/Ritonavir

J. Aberg, James A. Underberg, G. Morse, 2014, Journal of acquired immune deficiency syndromes.

Cardiovascular Risk Factor Control and Lifestyle Factors in Young to Middle-Aged Adults with Newly Diagnosed Obstructive Coronary Artery Disease

E. Fisher, J. Berger, J. Newman, 2019, Cardiology.